A cross sectional study to assess the efficacy of glycosylated fibronectin (GlyFn) estimation in prediction of the severity of disease in new onset hypertension in pregnancy from 24 weeks to term
Background: As hypertensive disorders of pregnancy contribute significantly to maternal and neonatal mortality and morbidity, it is very essential to diagnose which cases will eventually have severe disease. Glycosylated fibronectin (GlyFn) is a protein involved in vessel remodelling and inflammatio...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Barpeta Obstetrics and Gynaecological Society,
2023-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|